6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027

Solicitation / RFP / RFQ

This document is a solicitation for Metoprolol Tartrate IR Tablets. The Department of Veterans Affairs, National Acquisition Center, is procuring these pharmaceutical supplies.

• The primary deliverable is Metoprolol Tartrate IR Tablets.

• The contract period of performance is effective from 5/8/2026 to 5/7/2027.

• The solicitation number is 36E79725R0071.

• The Product Service Code (PSC) is 6505.

• The North American Industry Classification System (NAICS) Code is 325412.

• Not explicitly detailed in the provided text, but contact information for the Contract Specialist is available.

• No specific set-aside information is provided in this excerpt.

• The Contracting Office ZIP Code is 60141.

• The Contracting Office Address is Department of Veterans Affairs, OPAL / National Acquisition Center, Building 37, 1st Ave, One Block North of Cermak.

• The Point of Contact is Ray Roldan, Contract Specialist, at Raymond.roldan@va.gov.

Amendment / Modification

This amendment extends the deadline for the receipt of offers for solicitation 36E79725R0071.

• The original due date of November 18, 2025, has been extended.

• The new due date and time for receipt of offers is November 21, 2025, at 2:30 PM Central Time.

• The "HOUR & DATE for Receipt of Offers" is extended.

• Bidders are granted an extension to submit their offers. The new deadline is November 21, 2025, at 2:30 PM CST.

• All other terms and conditions of the original solicitation remain unchanged.

Solicitation / RFP / RFQ

This solicitation is for the procurement of Metoprolol Tartrate Tablets for the Department of Veterans Affairs (VA) and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs. The objective is to establish a supply source for these pharmaceutical products to ensure availability and consistent product for nationwide usage, obtaining volume-based, committed-use pricing.

• Procurement of Metoprolol Tartrate Tablets in various strengths and package sizes (100, 500, 1000 tablets per bottle).

• Offerors must provide an 11-digit National Drug Code (NDC) number unique to their company for each offered drug.

• Products must meet FDA standards and cGMP requirements.

• Bar code labeling conforming to GS1-128 or HIBCC standards is required.

• Compliance with Drug Supply Chain Security Act (DSCSA) requirements is mandatory.

• Packaging must include safety caps for bottles of 400 tablets or less and be compatible with automated dispensing units.

• Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.

• Period of Performance: Base Ordering Period of one year, with four one-year option periods, for a total potential duration of five years.

• Estimated Usage: Quantities are estimates only and do not guarantee purchase.

• Offers must be submitted via email in Microsoft Word or PDF format to specified addresses, including a scanned copy of the signed SF-1449.

• Proposals must include pricing for the base year and all four option years for all specified line items.

• Offers must include a 0.5% Cost Recovery Fee in all offered prices.

• Evaluation will be based on the lowest price technically acceptable offer.

• Technical acceptability includes meeting product descriptions, unique NDC numbers, FDA approval, FDA cGMP compliance, and manufacturing facility clearance.

• Offer due date: November 18, 2025, 2:30 PM CT.

• This acquisition is unrestricted.

• Other than small business concerns may be required to submit a subcontracting plan for contracts over $750,000.

• Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer.

• Attachments A and B list the VA and DoD Pharmaceutical Prime Vendor Contractors.

• Attachment C provides estimated annual usage quantities by agency.

• Attachment D provides a template for the Small Business Subcontracting Plan.